KLC1-ALK: a novel fusion in lung cancer identified using a formalin-fixed paraffin-embedded tissue only.

The promising results of anaplastic lymphoma kinase (ALK) inhibitors have changed the significance of ALK fusions in several types of cancer. These fusions are no longer mere research targets or diagnostic markers, but they are now directly linked to the therapeutic benefit of patients. However, mos...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Yuki Togashi, Manabu Soda, Seiji Sakata, Emiko Sugawara, Satoko Hatano, Reimi Asaka, Takashi Nakajima, Hiroyuki Mano, Kengo Takeuchi
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2012
Materias:
R
Q
Acceso en línea:https://doaj.org/article/3cd968b320cf479fb7e56c68f8941206
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!